Avidity Biosciences, Inc.
RNA
$26.57
-$1.53-5.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -322.30M | -280.49M | -252.45M | -228.68M | -212.22M |
| Total Depreciation and Amortization | 2.78M | 2.65M | 2.51M | 2.35M | 2.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.21M | 32.83M | 32.36M | 30.54M | 29.93M |
| Change in Net Operating Assets | -14.56M | 60.50M | 61.91M | 55.31M | 61.13M |
| Cash from Operations | -300.87M | -184.50M | -155.67M | -140.48M | -119.06M |
| Capital Expenditure | -7.07M | -4.01M | -3.23M | -3.32M | -4.23M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -847.14M | -734.98M | -284.82M | 36.19M | -125.84M |
| Cash from Investing | -854.20M | -738.99M | -288.06M | 32.86M | -130.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.05B | 1.07B | 726.71M | 318.80M | 93.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 141.40M | 141.40M | 141.40M | 141.55M | -- |
| Cash from Financing | 1.19B | 1.21B | 868.10M | 460.35M | 93.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.29M | 287.04M | 424.37M | 352.73M | -155.27M |
